Enhabit Past Earnings Performance
Past criteria checks 0/6
Enhabit's earnings have been declining at an average annual rate of -59.5%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 1.7% per year.
Key information
-59.5%
Earnings growth rate
-89.7%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -1.7% |
| Return on equity | -11.3% |
| Net Margin | -7.7% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Here's What Analysts Are Forecasting For Enhabit, Inc. (NYSE:EHAB) After Its Annual Results
Mar 09
The Market Doesn't Like What It Sees From Enhabit, Inc.'s (NYSE:EHAB) Revenues Yet
Mar 05Enhabit (NYSE:EHAB) Could Be Struggling To Allocate Capital
Feb 09A Look At The Intrinsic Value Of Enhabit, Inc. (NYSE:EHAB)
Oct 04Enhabit: 40% Slump In Pre-Tax Earnings, Payer Headwinds Remain In Situ, Reiterate Hold
Aug 18Enhabit: Difficult To Justify At 20x Earnings, Reiterate Hold
Jun 07An Intrinsic Calculation For Enhabit, Inc. (NYSE:EHAB) Suggests It's 24% Undervalued
May 31Enhabit beats Q4 top and bottom line estimates; initiates FY23 outlook
Feb 15Enhabit: Difficult Time Ahead According To Market Generated Data (Technical Analysis)
Jan 29Enhabit, Inc.'s (NYSE:EHAB) Intrinsic Value Is Potentially 91% Above Its Share Price
Jan 19Enhabit, Inc.'s (NYSE:EHAB) Shares Lagging The Market But So Is The Business
Dec 07Jana Partners adds stakes in Momentive, Freshpet, Enhabit in Q3, exits Conagra
Nov 14Enhabit acquires Texas-based Caring Hearts Hospice, expands national footprint
Oct 03Enhabit initiated Neutral at Citi on near-term concerns
Aug 19Enhabit Home Health & Hospice falls 13% after Non-GAAP EPS, revenue miss
Aug 01Enhabit: A Chip Off The Old Stock
Jul 18Revenue & Expenses BreakdownBeta
How Enhabit makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,046 | -80 | 442 | 0 |
| 30 Sep 23 | 1,049 | -169 | 432 | 0 |
| 30 Jun 23 | 1,056 | -158 | 430 | 0 |
| 31 Mar 23 | 1,062 | -64 | 425 | 0 |
| 31 Dec 22 | 1,071 | -40 | 415 | 0 |
| 30 Sep 22 | 1,084 | 84 | 414 | 0 |
| 30 Jun 22 | 1,092 | 97 | 410 | 0 |
| 31 Mar 22 | 1,110 | 109 | 414 | 0 |
| 31 Dec 21 | 1,107 | 111 | 413 | 0 |
| 31 Dec 20 | 1,078 | 75 | 398 | 0 |
| 31 Dec 19 | 1,092 | 24 | 466 | 0 |
Quality Earnings: EHAB is currently unprofitable.
Growing Profit Margin: EHAB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EHAB is unprofitable, and losses have increased over the past 5 years at a rate of 59.5% per year.
Accelerating Growth: Unable to compare EHAB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EHAB is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (12.5%).
Return on Equity
High ROE: EHAB has a negative Return on Equity (-11.26%), as it is currently unprofitable.